Houlihan Lokey, Inc.
HLI · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 2.26 | -1.52 | 0.82 | 14.19 |
| FCF Yield | 2.35% | -1.21% | 3.22% | 2.29% |
| EV / EBITDA | 73.95 | 80.20 | 57.96 | 69.83 |
| Quality | ||||
| ROIC | 3.71% | 3.24% | 4.12% | 3.44% |
| Gross Margin | 33.51% | 38.50% | 38.50% | 38.50% |
| Cash Conversion Ratio | 2.91 | -1.35 | 2.94 | 2.79 |
| Growth | ||||
| Revenue 3-Year CAGR | 12.87% | 11.15% | 9.71% | 6.91% |
| Free Cash Flow Growth | 322.91% | -142.11% | 31.43% | -6.12% |
| Safety | ||||
| Net Debt / EBITDA | -2.74 | -2.45 | -3.04 | -2.31 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 34.28 | 34.16 | 25.92 | 24.00 |